← Leaderboards
Magali Saint-Geniez
Schepens Eye Research Institute
$4,572,022
Attributed
$6,226,043
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2009–20$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$6,226,043 · 4
By mechanism
DP2$2,918,000 · 1
R01$2,797,198 · 2
R21$510,845 · 1
Top collaborators
- Zoltan P Arany3 shared
- Sule Cataltepe3 shared
- Kip M Connor3 shared
Most similar at Schepens Eye Research Institute
Same institution · by research overlap
- Ann Marshak-Rothstein$30,359,235
- Clement L Trempe$21,064
Others in their field
Top investigators on “Blindness”
- Randall J Bateman · Washington University$137,189,188
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$96,562,493
Research focus
BlindnessMouse ModelMediatingPhotoreceptorsRetinalVisionGene ExpressionResponseMetabolismRetinaInsightIn VivoMetabolicGeneticPhotoreceptor DegenerationPreventDiabetic RetinopathyOxidative DamageAdultGenetic ModelsAcuteMitochondriaAdenovirusesOxygen
Grant awards (10)
Sex dependent regulation of retinal degeneration$458,750
R01 · FY2020 · EY
Sex dependent regulation of retinal degeneration$240,019
R01 · FY2020 · EY
Sex dependent regulation of retinal degeneration$476,250
R01 · FY2019 · EY
PGC-1 coactivators in photoreceptor development and survival$511,429
R01 · FY2015 · EY
PGC-1 coactivators in photoreceptor development and survival$535,738
R01 · FY2014 · EY
PGC-1 coactivators in photoreceptor development and survival$575,012
R01 · FY2013 · EY
Fatty Acid Binding Protein and Pathological Retinal Vascularization$224,600
R21 · FY2012 · EY
Fatty Acid Binding Protein and Pathological Retinal Vascularization$47,000
R21 · FY2012 · EY
Fatty Acid Binding Protein and Pathological Retinal Vascularization$239,245
R21 · FY2011 · EY
Bioengineering of Bruch's Membrane for the treatment of Age-related Macular Degen$2,918,000
DP2 · FY2009 · OD · contact PI